PINZANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 15.815
EU - Europa 10.477
AS - Asia 5.530
SA - Sud America 666
OC - Oceania 147
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 75
Totale 32.853
Nazione #
US - Stati Uniti d'America 15.588
RU - Federazione Russa 3.143
PL - Polonia 1.766
IT - Italia 1.709
SG - Singapore 1.540
CN - Cina 1.191
HK - Hong Kong 1.038
SE - Svezia 901
IE - Irlanda 802
VN - Vietnam 657
UA - Ucraina 628
BR - Brasile 552
DE - Germania 534
KR - Corea 474
FI - Finlandia 304
FR - Francia 293
GB - Regno Unito 221
IN - India 190
AU - Australia 139
CA - Canada 130
JO - Giordania 75
JP - Giappone 71
TR - Turchia 67
BD - Bangladesh 50
AR - Argentina 48
CH - Svizzera 44
BE - Belgio 36
MX - Messico 33
NL - Olanda 33
ZA - Sudafrica 33
ID - Indonesia 32
CI - Costa d'Avorio 27
IQ - Iraq 26
PK - Pakistan 25
SC - Seychelles 23
ES - Italia 20
EC - Ecuador 16
JM - Giamaica 16
UZ - Uzbekistan 16
NG - Nigeria 14
NP - Nepal 13
VE - Venezuela 13
CO - Colombia 12
MY - Malesia 12
CL - Cile 10
SA - Arabia Saudita 10
MA - Marocco 9
TT - Trinidad e Tobago 9
KE - Kenya 8
NZ - Nuova Zelanda 8
EG - Egitto 7
HN - Honduras 7
TN - Tunisia 7
CR - Costa Rica 6
PE - Perù 6
AZ - Azerbaigian 5
LT - Lituania 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BB - Barbados 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
EU - Europa 4
LV - Lettonia 4
PA - Panama 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
AT - Austria 2
BJ - Benin 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CD - Congo 1
CG - Congo 1
HR - Croazia 1
IL - Israele 1
Totale 32.770
Città #
Santa Clara 2.720
Warsaw 1.759
Fairfield 1.488
Ashburn 1.359
Singapore 1.025
Chandler 998
Jacksonville 981
Hong Kong 836
Dublin 800
Woodbridge 662
Cambridge 599
Seattle 586
Houston 509
Wilmington 500
Seoul 471
Milan 450
San Jose 383
Ann Arbor 328
Beijing 314
Council Bluffs 240
The Dalles 225
Los Angeles 218
Princeton 216
Ho Chi Minh City 207
Buffalo 201
Boardman 183
Lauterbourg 182
Boston 167
Hefei 163
Rome 157
Hanoi 146
Melbourne 138
Mumbai 118
Dallas 115
Lawrence 113
Altamura 112
Medford 100
Munich 98
Moscow 93
Columbus 86
Florence 73
San Diego 69
New York 68
Tokyo 63
Kent 62
Helsinki 56
Shanghai 55
Paris 51
São Paulo 51
Turin 49
Naples 45
London 44
Norwalk 43
Izmir 42
Orem 42
Turku 38
Bern 36
Brussels 36
Frankfurt Am Main 35
Auburn Hills 29
Bologna 28
Abidjan 27
Chicago 27
Andover 26
Frankfurt am Main 25
Guangzhou 24
Haiphong 24
Hillsboro 24
Montreal 24
Redondo Beach 24
Toronto 24
Da Nang 23
Palermo 23
Verona 23
West Jordan 22
Bari 21
Phoenix 21
Jakarta 20
Figino 19
Brescia 18
Dong Ket 18
Manchester 18
Tianjin 18
Yubileyny 18
Chennai 17
North Bergen 17
San Francisco 17
Miano 16
Bremen 15
Brooklyn 15
Dearborn 14
Hải Dương 14
Abuja 13
Biên Hòa 13
Tashkent 13
Curitiba 12
Miami 12
Ottawa 12
Padua 12
Catania 11
Totale 21.795
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 377
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 345
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. 340
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 322
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 320
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 310
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 303
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 300
Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. 298
Intermittent fever in a patient with apparent fatty liver 282
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 272
Welcome to Fibrogenesis & Tissue Repair 260
Hepatic wound repair. 243
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. 243
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 241
Acute viral hepatitis increases liver stiffness values measured by transient elastography 240
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. 236
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 234
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 226
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 225
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 225
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 223
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 220
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 218
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells 214
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 214
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 213
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 212
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 208
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 208
ADMA correlates with portal pressure in patients with compensated cirrhosis. 207
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. 206
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 200
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 199
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation 198
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. 197
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 196
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 192
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 192
MARCKS Actin Binding Capacity Mediates Actin Filament Assembly During Mitosis In Human Hepatic Stellate Cells. 192
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 192
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 192
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 191
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 190
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 187
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 186
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 183
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 183
Nuclear localization of TRK-A in liver cells. 182
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 182
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis 182
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 180
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. 180
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. 179
Expression of platelet-derived growth factor in a model of acute liver injury. 176
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 176
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 174
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 174
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 173
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts. 173
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. 173
Binding of hepatitis C virus envelope protein E2 to CD81 induces the expression of MMP-2 (Gelatinase A) in human hepatic stellate cells. 171
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 171
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis 171
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 171
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 171
Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. 171
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 168
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 168
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 168
Albumin and stellate cell activation: wonders will never cease! 166
Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. 166
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 166
Angiogenesis in liver disease. 165
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms 164
Defective Chromosome Segregation Causes DNA Damage and Chromosome Abnormalities In Human Hepatocellular Carcinoma 164
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 164
A Secreted Form of ADAM9 by Hepatic Stellate Cells Induces Tumor Invasion Through Stromal-tumor Interactions 163
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 162
Dose-dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells 160
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 160
Actions of platelet-derived growth factor isoforms in mesangial cells. 159
Progression of fibrosis in chronic liver diseases: time to tally the score. 159
Undulin RNA and protein expression in normal and fibrotic human liver. 158
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 157
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. 156
Stellate Cells 155
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 155
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes 155
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 154
Serum markers detect the presence of liver fibrosis: a cohort study. 153
Transforming growth factor beta1 regulates platelet derived growth factor receptor beta subunit in human liver fat storing cells 153
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. 152
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 152
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 152
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 151
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 151
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 150
Organization of the lymphoid tissue in livers with chronic active hepatitis. 150
The cellular and molecular basis of liver fibrogenesis. 149
Totale 19.810
Categoria #
all - tutte 86.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.294 0 134 52 60 58 64 51 75 86 51 304 359
2022/20233.661 375 460 153 346 351 687 453 232 441 21 84 58
2023/20241.048 63 151 229 58 46 111 25 249 7 33 51 25
2024/20258.201 235 929 579 1.315 2.462 881 116 465 472 221 270 256
2025/20268.261 1.025 1.179 566 448 893 262 956 399 604 460 177 1.292
2026/2027636 251 385 0 0 0 0 0 0 0 0 0 0
Totale 32.853